Clinical Trials Directory

Trials / Suspended

SuspendedNCT05041829

Dietary Sodium Intake and Blood Pressure in Living Kidney Donors

Dietary Sodium Intake and Blood Pressure in Living Kidney Donors: A Pilot Single-Center Crossover Single-Blind Randomized Controlled Trial

Status
Suspended
Phase
N/A
Study type
Interventional
Enrollment
24 (estimated)
Sponsor
University of California, Irvine · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

This is a pilot study to determine the feasibility of the study design and examine the main outcome whether low dietary sodium intake is superior to high dietary sodium intake in controlling blood pressure to be within the normotensive range in living kidney donors.

Detailed description

This is a pilot study to determine the feasibility of the study design and examine the main outcome whether low dietary sodium intake \<2.3 g/day (\<100 mmol/day) is superior to high dietary sodium intake ≥4 - \<6 g/day (≥174 - \<261 mmo/day) in controlling blood pressure (BP) to be within normotensive range, lowering systolic and diastolic blood pressures (SBP and DBP) from the baseline blood pressures, and decreasing the risk of hypertension, worsening kidney function, and proteinuria in living kidney donors between 5 and 12 months after living kidney donation?.

Conditions

Interventions

TypeNameDescription
OTHERDietary sodiumLow sodium diet with sodium of \<2.3 g/day (\<100 mmol/day) and high sodium diet with sodium of ≥4 - \<6 g/day (≥174 - \<261 mmo/day)

Timeline

Start date
2021-11-03
Primary completion
2027-06-30
Completion
2028-06-30
First posted
2021-09-13
Last updated
2025-08-21

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT05041829. Inclusion in this directory is not an endorsement.